MILAGROS ZISA: Open Payments
NPI 1851976229 · RUTHERFORD, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$376 in 12 payments from 7 companies in 2025. Trend: 2023 $105 · 2024 $48 · 2025 $376
Food & beverage: $376
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $151 |
| Lilly USA, LLC | 1 | $96 |
| Philips North America LLC | 1 | $43 |
| ViiV Healthcare Company | 2 | $35 |
| Novo Nordisk Inc | 1 | $19 |
| Astellas Pharma US Inc | 1 | $17 |
| Evofem Biosciences, Inc. | 2 | $15 |
Products named: XIFAXAN, MOUNJARO, MCOT, APRETUDE, Wegovy, Veozah, Phexxi.
Industry payments across NJ — which companies pay providers there.
